Schedule 13G ownership disclosure
RETROPHIN INC
Security class unavailable · CUSIP: 761299106
Event date: 2019-07-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000891092-19-008367
- Form type
- SC 13G
- Filer
- Travere Therapeutics, Inc.
- CIK
- CIK 1438533
- Filed
- Aug 12, 2019
- Reporting period
- Jul 31, 2019
- Description
- Schedule 13G beneficial ownership